Middle East Pharmaceutical Industries Company (TADAWUL: 4016)
Saudi Arabia
· Delayed Price · Currency is SAR
118.60
-1.60 (-1.33%)
Dec 19, 2024, 3:19 PM AST
Middle East Pharmaceutical Industries Company Ratios and Metrics
Market cap in millions SAR. Fiscal year is January - December.
Millions SAR. Fiscal year is Jan - Dec.
| Current | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
| Dec '24 Dec 19, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 |
| Debt / Equity Ratio | 0.23 | 0.20 | 0.30 | 0.33 | 0.25 |
| Debt / EBITDA Ratio | 0.73 | 0.70 | 1.11 | 1.05 | 0.72 |
| Debt / FCF Ratio | 1.76 | 0.83 | 1.44 | 3.44 | 5.49 |
| Asset Turnover | - | 0.76 | 0.70 | 0.73 | - |
| Inventory Turnover | - | 1.40 | 1.37 | 1.45 | - |
| Quick Ratio | 1.31 | 1.53 | 1.36 | 1.59 | 1.52 |
| Current Ratio | 2.23 | 2.45 | 2.22 | 2.29 | 2.66 |
| Return on Equity (ROE) | - | 22.44% | 21.72% | 25.52% | - |
| Return on Assets (ROA) | - | 10.92% | 10.10% | 12.09% | - |
| Return on Capital (ROIC) | - | 13.25% | 12.06% | 14.23% | - |
| Payout Ratio | 33.56% | 54.69% | 61.14% | 56.12% | 49.80% |
Source: S&P Capital IQ. Standard template.
Financial Sources.